Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Ledipasvir/Sofosbuvir fixed-dose combination in patients with chronic genotype 1 or 4 HCV for peri-operative live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/Sofosbuvir fixed-dose combination (Ledipasvir + Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05